Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fast and Accurate Diagnostic Test Introduced for Meningitis

By LabMedica International staff writers
Posted on 12 May 2009
A novel, fast-acting multiplex polymerase chain reaction (PCR) diagnostic technique simultaneously verifies a complex range of pathogens that indicate meningitis, a severely debilitating infection that if not diagnosed and treated quickly can result in death.

The Seeplex meningitis ACE detection tests for 12 meningitis-causing pathogens: five bacteria--Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, Listeria monocytogenes, and Streptococcus agalactiae; and seven viruses-- Herpes simplex virus 1 and 2 (HSV1, HSV2), varicella zoster virus (VZV, or human herpesvirus 3), Epstein-Bar virus (EBV, or human herpesvirus 4), Cytomegalovirus (CMV), human herpesvirus 6 (HHV6), and enteroviruses from cerebrospinal fluid (CSF).

Traditional methods of diagnosing meningitis rely on culture and Gram staining, both of which have notable performance limitations that can result in inaccurate diagnosis of meningitis. More...
Culture of CSF takes more than three days to obtain test results that can be unclear because of recent antibiotic use, contamination, or fastidious bacteria.

Gram staining is one of the oldest microbiologic tests that distinguish between Gram-positive and Gram-negative bacteria. But Gram staining does not identify the individual strain of bacteria. This type of detailed information is necessary for applying the correct antibiotics that can destroy certain meningitis causing bacteria, and prevent its spread to other people.

The World Health Organization (WHO; Geneva, Switzerland) estimates that 1.2 million cases of bacterial meningitis occur every year around the world, out of which 135,000 are fatal. The WHO postulates that a significant number of viral meningitis infections go undiagnosed in the absence of a standard diagnostic tool to determine the infections.

Seeplex technology is provided by Seegene (Seoul, Korea), a biotechnology company specialized in molecular diagnostics and research applications. "Seeplex Meningitis ACE detection provides accurate, rapid and cost-effective meningitis diagnostics. The test is a clear break from traditional methods of diagnosing meningitis, taking only six hours to detect either bacterial or viral meningitis infection in an easy to use testing format," said Dr. Jong-Yoon Chun, founder and CEO of Seegene. "This test will help to save lives and prevent unnecessary antibiotic prescriptions by providing precise information of meningitis causing pathogens at the earliest possible stage."

Related Links:

World Health Organization
Seegene



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.